Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

Neeraj Saini; David Marin; Celina Ledesma; Ruby Delgado; Gabriela Rondon; Uday R. Popat; Qaiser Bashir; Chitra M. Hosing; Yago Nieto; Amin M. Alousi; Muzaffar H. Qazilbash; Stefan Ciurea; Elizabeth Shpall; Issa Khouri; Hagop Kantarjian; Elias Jabbour; Farhad Ravandi; Richard E. Champlin; Partow Kebriaei

doi:10.1182/blood.2019004685

Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

Neeraj Saini, David Marin, Celina Ledesma, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Qaiser Bashir, Chitra M. Hosing, Yago Nieto, Amin M. Alousi, Muzaffar H. Qazilbash, Stefan Ciurea, Elizabeth Shpall, Issa Khouri, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Richard E. Champlin, Partow Kebriaei

Research output: Contribution to journal › Letter › peer-review

35 Scopus citations

Original language	English (US)
Pages (from-to)	1786-1789
Number of pages	4
Journal	Blood
Volume	136
Issue number	15
DOIs	https://doi.org/10.1182/blood.2019004685
State	Published - Oct 8 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2019004685

Cite this

Saini, N., Marin, D., Ledesma, C., Delgado, R., Rondon, G., Popat, U. R., Bashir, Q., Hosing, C. M., Nieto, Y., Alousi, A. M., Qazilbash, M. H., Ciurea, S., Shpall, E., Khouri, I., Kantarjian, H., Jabbour, E., Ravandi, F., Champlin, R. E., & Kebriaei, P. (2020). Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL. Blood, 136(15), 1786-1789. https://doi.org/10.1182/blood.2019004685

Saini, N , Marin, D, Ledesma, C, Delgado, R, Rondon, G , Popat, UR , Bashir, Q , Hosing, CM , Nieto, Y , Alousi, AM , Qazilbash, MH, Ciurea, S, Shpall, E , Khouri, I , Kantarjian, H , Jabbour, E , Ravandi, F , Champlin, RE & Kebriaei, P 2020, 'Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL', Blood, vol. 136, no. 15, pp. 1786-1789. https://doi.org/10.1182/blood.2019004685

@article{8c63eb1821a548318afc4a37a31aabad,

title = "Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL",

author = "Neeraj Saini and David Marin and Celina Ledesma and Ruby Delgado and Gabriela Rondon and Popat, {Uday R.} and Qaiser Bashir and Hosing, {Chitra M.} and Yago Nieto and Alousi, {Amin M.} and Qazilbash, {Muzaffar H.} and Stefan Ciurea and Elizabeth Shpall and Issa Khouri and Hagop Kantarjian and Elias Jabbour and Farhad Ravandi and Champlin, {Richard E.} and Partow Kebriaei",

note = "Funding Information: research funding from BMS, Amgen, Xencor, Abbvie, and Orsenix; has served on advisory boards of BMS, Amgen, Astellas, AstraZeneca, Celgene, Orsenix, and Agios; and has received honoraria from BMS, Celgene, Astellas, Abbvie, AstraZeneca, Novartis, Orsenix, and Agios. The remaining authors declare no competing financial interests.",

year = "2020",

month = oct,

day = "8",

doi = "10.1182/blood.2019004685",

language = "English (US)",

volume = "136",

pages = "1786--1789",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "15",

}

TY - JOUR

T1 - Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

AU - Saini, Neeraj

AU - Marin, David

AU - Ledesma, Celina

AU - Delgado, Ruby

AU - Rondon, Gabriela

AU - Popat, Uday R.

AU - Bashir, Qaiser

AU - Hosing, Chitra M.

AU - Nieto, Yago

AU - Alousi, Amin M.

AU - Qazilbash, Muzaffar H.

AU - Ciurea, Stefan

AU - Shpall, Elizabeth

AU - Khouri, Issa

AU - Kantarjian, Hagop

AU - Jabbour, Elias

AU - Ravandi, Farhad

AU - Champlin, Richard E.

AU - Kebriaei, Partow

N1 - Funding Information: research funding from BMS, Amgen, Xencor, Abbvie, and Orsenix; has served on advisory boards of BMS, Amgen, Astellas, AstraZeneca, Celgene, Orsenix, and Agios; and has received honoraria from BMS, Celgene, Astellas, Abbvie, AstraZeneca, Novartis, Orsenix, and Agios. The remaining authors declare no competing financial interests.

PY - 2020/10/8

Y1 - 2020/10/8

UR - http://www.scopus.com/inward/record.url?scp=85092749903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092749903&partnerID=8YFLogxK

U2 - 10.1182/blood.2019004685

DO - 10.1182/blood.2019004685

M3 - Letter

C2 - 32492706

AN - SCOPUS:85092749903

SN - 0006-4971

VL - 136

SP - 1786

EP - 1789

JO - Blood

JF - Blood

IS - 15

ER -

Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this